<DOC>
	<DOC>NCT00444457</DOC>
	<brief_summary>The purpose of this study will be to evaluate safety, tolerability and immunogenicity of three lots of 13-valent pneumococcal vaccine given to healthy infants. Lots will be studied for consistency of the immune response, as well as for non-inferiority and safety as compared to 7-valent Pneumococcal Conjugate Vaccine.</brief_summary>
	<brief_title>Study Evaluating 13-valent Pneumococcal Conjugate Vaccine In Healthy Infants</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Inclusion criteria: Healthy 2 month old infants Available for the duration of the study and reachable by telephone Able to complete two blood drawing procedures during the study Exclusion criteria: Previous vaccination, contraindication or history of allergic reaction to vaccines or vaccine components Bleeding disorder, immune deficiency or significant chronic or congenital disease Previous receipt of blood products or immune globulin</criteria>
	<gender>All</gender>
	<minimum_age>42 Days</minimum_age>
	<maximum_age>98 Days</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Vaccine</keyword>
	<keyword>Infants</keyword>
	<keyword>Pneumococcal Conjugate Vaccines</keyword>
	<keyword>Vaccines, Pneumococcal</keyword>
</DOC>